Home » Topics » Science » New compound

New compound
RSS

Cell signaling inhibitor, CTC-119, antitumor activity reported

May 31, 1996

More protein farnesyltransferase inhibitors from Warner-Lambert

May 31, 1996

MuIGIF with interferon gamma production-stimulating properties identified

May 31, 1996

Single-chain immunotoxin targeted to the CD40 antigen effect as cytotoxic agent

May 31, 1996

Research of a recombinant fusion protein in human breast cancer disclosed

May 31, 1996

Daiwa's MGN-3 demonstrates immunotherapeutic activity

May 31, 1996

RPR-112378: A new inhibitor of tubulin polymerization

May 31, 1996

NSC-314622, a new topoisomerase I-targeted antitumor, described by NIH

May 31, 1996

TAS-103, a dual inhibitor of DNA topoisomerase I and II

May 31, 1996

Rebeccamycin analogue undergoes phase I trial

May 31, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...